Longstanding contracts present a problem for successful German manufacturers. Rising prices for raw materials are cutting ...

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

Financing follows completion of enrollment of Phase 3 NATiV3 study evaluating lanifibranor in MASH and satisfaction of other specified conditions. Daix (France), New York City (New York, United States ...

Julia Holter, a Los Angeles-based composer and multi-instrumentalist, will return to Milwaukee for her first hometown ...

Take 3 will bring its "Where Rock Meets Bach" show that mashes up pop and classical music to the Lied Center for Performing ...

Researchers have found a new ally in the fight against a serious liver disease: a symbiotic gut-dwelling fungus that produces a molecule shown to be ...

General and Administrative (G&A) Expenses. G&A expenses were $11.5 million for the three months ended March 31, 2025, compared to $9.8 million for the three months ended March 31, 2024. The increase ...

Metabolic liver disease might not get as much attention as heart disease or diabetes, but it affects around one in four ...

Semaglutide effectively treats liver disease in two thirds of patients, new research has found.Results from the ESSENCE phase 3 clinical trial ...

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK ...

Semaglutide effectively treats liver disease in two thirds of patients, new research has found. Semaglutide effectively treats liver disease in two thirds of patients, new research has found.